| 000 | 01311 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511200529.0 | ||
| 264 | 0 | _c19911008 | |
| 008 | 199110s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(91)91235-m _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBriggs, D C | |
| 245 | 0 | 0 |
_aImmunogenetic prediction of pulmonary fibrosis in systemic sclerosis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1991 |
||
| 300 |
_a661-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 |
_aDNA _xanalysis |
| 650 | 0 | 4 | _aDNA Topoisomerases, Type I |
| 650 | 0 | 4 |
_aHLA-DR3 Antigen _xgenetics |
| 650 | 0 | 4 |
_aHLA-DR5 Antigen _xgenetics |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNuclear Proteins _ximmunology |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xetiology |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
| 700 | 1 | _aVaughan, R W | |
| 700 | 1 | _aWelsh, K I | |
| 700 | 1 | _aMyers, A | |
| 700 | 1 | _aduBois, R M | |
| 700 | 1 | _aBlack, C M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 338 _gno. 8768 _gp. 661-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(91)91235-m _zAvailable from publisher's website |
| 999 |
_c1685890 _d1685890 |
||